title: STING and TRIF Contribute to Mouse Sepsis, Depending on Severity of the Disease Model.
abstract: IFN regulatory factor (IRF)3 plays a detrimental role in the cecal ligation and puncture (CLP) mouse model of sepsis. However, it is unclear which pathway activates IRF3 in this context. In this report, we investigate two pathways that activate IRF3: the Stimulator of Interferon Genes (STING) pathway (that senses cytosolic DNA) and the TIR-domain-containing adapter-inducing interferon-β (TRIF) pathway (that senses dsRNA and LPS via Toll-like receptor 3 and 4). Initially, we examine the impact of these pathways using a severe CLP model (∼90% mortality). Both STING-KO and TRIF-KO mice are protected from severe sepsis, exhibiting reduced mortality, disease score, hypothermia, and inflammatory cytokines relative to WT counterparts. STING/TRIF-DKO mice exhibit a similar phenotype to each of the single KO strains, suggesting that these pathways have an interrelated function. Subsequently, we examine the impact of these pathways using a moderate CLP model incorporating clinical treatments (Lactated Ringer Solution and antibiotics, ∼36% mortality). In this case, STING-KO mice show a similar phenotype to WT counterparts, while TRIF-KO mice show improved disease score and hypothermia. During sepsis, innate immune receptors recognize bacterial ligands and host-derived danger signals, including cell-free DNA released into the circulation. We show that IRF3 is activated in cultured macrophages treated with bacteria derived from the mouse cecum, dependent on TRIF, and in macrophages treated with mouse genomic DNA/Lipofectamine 2000, dependent on STING. Together, our data demonstrate that both the STING and TRIF pathways can promote sepsis pathogenesis; however, their contribution depends on the severity of the disease model. We show that bacteria are abundant in the peritoneum following both severe and moderate CLP, while cell-free DNA is more highly elevated in the serum following severe CLP compared with sham and moderate CLP. Hence, the presence of bacteria and cell-free DNA may explain the variable phenotypes in our severe CLP model (dependent on TRIF and STING) versus our moderate CLP model (dependent on TRIF only).
authors.affiliation: Center of Emphasis in Infectious Diseases, Department of Biomedical Sciences, Paul L Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, Texas.
authors.forename: Erica L
authors.initials: EL
authors.lastname: Heipertz
authors.forename: Jourdan
authors.initials: J
authors.lastname: Harper
authors.forename: Wendy E
authors.initials: WE
authors.lastname: Walker
mesh_terms: D033942:Adaptor Proteins, Vesicular Transport / Q000235:genetics / Q000378:metabolism*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D004195:Disease Models, Animal; D007113:Immunity, Innate / Q000235:genetics / Q000502:physiology*; D007249:Inflammation / Q000235:genetics / Q000276:immunology; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D012151:Resuscitation; D018805:Sepsis / Q000276:immunology / Q000378:metabolism* / Q000473:pathology*; D000099197:STING Protein
chemical_list: D033942:Adaptor Proteins, Vesicular Transport; D000900:Anti-Bacterial Agents; D008565:Membrane Proteins; C530855:Sting1 protein, mouse; D000099197:STING Protein; C476286:Ticam1 protein, mouse